ENDOVASCULAR  NEUROLOGIST  TO  SPEAK  ON  SPECIALIZED STROKE  TREATMENT  IN  McALLEN 

Breaking News
3453

Translate to Spanish or other 102 languages!

Mega Doctor News—

- Advertisement -

Dr. Ameer Hassan to Speak at Free “Dessert with the Doctor”

Tuesday, Nov. 11 at McAllen Public Library

McALLEN – Dr. Ameer Hassan, Endovascular Neurologist, will speak and answer questions on “Surviving a Stroke: Learn about Important Tools Available to Help Stop a Stroke from Progressing and Causing Permanent Disability”, during a free “Dessert with a Doctor” event on Tuesday, Nov. 11, at 6:30 p.m. at the McAllen Public Library, 4001 N. 23rd Street (just north of Nolana).   Dr. Hassan will also discuss specialized endovascular stroke treatment which can extend the window of time for care of stroke patients and reduce the chances of permanent disability.  The event is free and open to the public, and attendees are invited to enjoy a free heart-healthy dessert, compliments of Valley Baptist Medical Center.  For more information or to RSVP, please call 1-888-902-5433.

- Advertisement -

 

- Advertisement -
- Advertisement -

Latest news

- Advertisement -
Previous article
Unprecedented $10 million Federal Grant will boost the Valley
Next article
Foster, Cigarroa, Reyes in full support for Vaquero and President Guy Bailey

More Articles

Texas Oncology Expands Cancer Care With New McAllen West Clinic

Texas Oncology celebrated the grand opening of its McAllen West clinic Sept. 29, expanding cancer treatment, diagnostic, and research capabilities in the Rio Grande Valley as the organization continues its presence in the region, spanning more than 40 years.

Multicancer Blood Test Detects 17 Cancer Types in Large Prospective Study

A large prospective study published in Nature Medicine found that a blood test designed to detect multiple cancers identified cancer signals across 17 broad cancer types, such as ovarian, lung, breast and colorectal cancers, and many which do not have recommended screening tests.

Pancreatic Cancer Patients Gain Early Access to Experimental Drug Daraxonrasib Following Fast-Track FDA Decision

The U.S. Food and Drug Administration is announcing that it issued a “safe to proceed” letter to Revolution Medicines, allowing the sponsor to initiate an expanded access treatment protocol (EAP) for its experimental pancreatic cancer drug, daraxonrasib.

DSHS Confirms First West Nile Case in Texas in 2026

The Texas Department of State Health Services is reporting this year’s first case of West Nile illness in a resident of Harris County. Health officials confirmed the resident was diagnosed with West Nile virus neuroinvasive disease. 
- Advertisement -